Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Elon Musk says he's on weight loss drug
Musk Tests Mounjaro, Ozempic, Wegovy: Which Weight-Loss Drug Won Him Over?
Mounjaro and Ozempic are both GLP-1 receptors that can be used to help people with diabetes. The treatments are also increasing in popularity as weight-loss options for people around the world. When it comes to the two weight-loss drug options, Musk shared his personal takes on both.
Elon Musk dubs himself "Ozempic Santa" as weight loss drugs go mainstream
Elon Musk showed off a trimmer figure in a holiday social media post on Wednesday while revealing that he has been taking an anti-obesity drug to shed pounds. Why it matters: Musk's post highlighted just how mainstream weight-loss drugs like Ozempic and Wegovy have become in recent years as public figures openly admit to using them,
Elon Musk Shares Christmas Weight-Loss Post: 'Ozempic Santa'
Elon Musk has admitted to taking a weight-loss drug in a Christmas Day post on X, formerly Twitter, as he shared a picture of himself wearing a Santa costume. "Ozempic Santa," the Tesla and SpaceX CEO posted alongside a photo of himself in the classic red outfit and white beard.
Weight loss drug gets US nod to treat sleep apnea
F.D.A. Approves Weight Loss Drug to Treat Obstructive Sleep Apnea
Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration on Friday approved the weight loss drug Zepbound to treat obstructive sleep apnea. It is the first prescription medication approved to treat the common sleep disorder.
FDA: Weight loss drug Zepbound, diabetes drug Mounjaro no longer in shortage
Consumers who take copies of the weight loss drug Zepbound and diabetes drug Mounjaro will need to find a new source for these medications.
FDA approves weight-loss drug Zepbound for obstructive sleep apnea
The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.
1d
Off-brand versions of Lilly weight loss drug must be pulled off market, could mean higher prices
The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...
1d
on MSN
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to ...
2d
Retail investors buy Novo dip after disappointing weight-loss drug data
U.S. retail investor fund flows into Novo Nordisk surged 32-fold on Friday, as the Danish drugmaker's weaker-than-expected ...
3d
on MSN
'Mrs. Doubtfire' star down 120 pounds after weight-loss drug makes him feel 'like a normal person'
"Hairspray" actor Harvey Fierstein, who weighed 310 pounds at his heaviest, has lost 120 pounds after taking the weigh-loss ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Ozempic
Zepbound
Novo Nordisk
Eli Lilly
Mounjaro
Feedback